Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AllCells supplies high-quality human hematological tissues and primary immune cell products under GMP and RUO standards to support basic research through commercialization in the cell and gene therapy field. The company has built one of the largest recallable donor pools globally with rapid delivery capabilities. It was acquired by Discovery Life Sciences in July 2022 to further expand its reach as an integrated provider of cellular starting materials with analytics for CGT development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AllCells.